Marty Nazzaro
Geschäftsführer bei Inflammasome Therapeutics, Inc.
Aktive Positionen von Marty Nazzaro
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Inflammasome Therapeutics, Inc.
 Inflammasome Therapeutics, Inc. BiotechnologyHealth Technology Inflammasome Therapeutics, Inc. develops therapies for prevalent and degenerative diseases. The American company was founded in 2016 by Jayakrishna Ambati and Paul Ashton. Paul Ashton has been the CEO since 2016. | Geschäftsführer | 01.03.2020 | - |
Karriereverlauf von Marty Nazzaro
Ehemalige bekannte Positionen von Marty Nazzaro
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Control Delivery Systems, Inc.
 Control Delivery Systems, Inc. Medical SpecialtiesHealth Technology Control Delivery Systems Inc. designs, develops and manufactures drug delivery products. The products are designed to deliver precise quantities of drugs to difficult-to-treat areas of the body. The company was founded in 1991 and is headquartered in Watertown, MA. | Corporate Officer/Principal | - | - |
| EYEPOINT PHARMACEUTICALS, INC. | Geschäftsführer | 01.05.2006 | - |
| Corporate Officer/Principal | 19.10.2009 | 19.10.2009 |
Ausbildung von Marty Nazzaro
| Suffolk University | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 4 |
| Australien | 2 |
Operativ
| Chief Operating Officer | 2 |
| Corporate Officer/Principal | 2 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| EYEPOINT PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Control Delivery Systems, Inc.
Control Delivery Systems, Inc. Medical SpecialtiesHealth Technology Control Delivery Systems Inc. designs, develops and manufactures drug delivery products. The products are designed to deliver precise quantities of drugs to difficult-to-treat areas of the body. The company was founded in 1991 and is headquartered in Watertown, MA. | Health Technology |
Inflammasome Therapeutics, Inc.
Inflammasome Therapeutics, Inc. BiotechnologyHealth Technology Inflammasome Therapeutics, Inc. develops therapies for prevalent and degenerative diseases. The American company was founded in 2016 by Jayakrishna Ambati and Paul Ashton. Paul Ashton has been the CEO since 2016. | Health Technology |
- Börse
- Insiders
- Marty Nazzaro
- Erfahrung